|
Sign In to gain access to subscriptions and/or personal tools.
|
Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration
A Zonana-Nacach
A Camargo-Coronel
P Yáñez
M de Lourdes Sánchez
F J Jáimenez-Balderas
J Aceves-Avila
P Martínez-Osuna
J Fuentes
F Medina
A Fraga
Department of Rheumatology, Hospital Especialidades Centro Médico Nacional, ‘Siglo XXI’, Instituto Mexicano del Seguro Social, México City, México 06720
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index is a validated instrument specifically designed to ascertain damage in SLE; this instrument has been applied mainly to Caucasians and African-American SLE patients. The objective of this study was to assess damage using the SLICC/ACR Damage Index in Mexican SLE patients. The SLICC/ACR Damage Index was applied to 210 consecutive SLE patients with disease of variable duration. The SLICC/ACR Damage Index was assessed by review of hospital clinical records, interview and physical examination. One hundred and seventeen (55.5%) patients had some damage. The proportion of patients with damage increased significantly with disease duration (33% at 1–60 months, 66% at 61–120 months and 70% at ≥121 months, P < 0.001). The main organ systems involved were musculoskeletal (osteonecrosis), neuropsychiatric (neuropathy, seizures), gonadal (amenorrhea prior to age 40 years), ocular (cataracts), renal (glomerular filtration < 50%) and peripheral vascular (permanent damage by venous thrombosis). Damage was frequent, increased over time, particularly for ocular, renal, musculoskeletal and gonadal. Patients who experienced damage were older, had a longer disease duration, a greater number of ACR criteria at diagnosis, and were more likely to have renal involvement and antibodies to dsDNA. The damage occurred in many different domains and started to develop early after disease onset. Mexican patients had more peripheral vascular and gonadal involvement compared with published data from non-Hispanic SLE populations.
Key Words: SLE • damage • disease course • prognosis • outcome
Lupus, Vol. 7, No. 2,
119-123 (1998)
DOI: 10.1191/096120398678919831
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Moorthy, M. Peterson, M. Baratelli, A. Hassett, T. Lehman, and the International SMILEY(C) Collaborative Group
Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort
Lupus,
January 1, 2010;
19(1):
83 - 88.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Burgos, L. Vila, J. Reveille, and G. Alarcon
Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX)
Lupus,
December 1, 2009;
18(14):
1303 - 1308.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. G. Uribe, J. Romero-Diaz, M. Apte, M. Fernandez, P. I. Burgos, J. D. Reveille, J. Sanchez-Guerrero, and G. S. Alarcon
Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico
Rheumatology,
November 1, 2009;
48(11):
1392 - 1397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Pons-Estel, J Sanchez-Guerrero, J Romero-Diaz, A Iglesias-Gamarra, E Bonfa, E. Borba, S. Shinjo, S Bernatsky, A Clarke, M. Garcia, et al.
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal
Lupus,
October 1, 2009;
18(12):
1033 - 1052.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Gonzalez, G. Pons-Estel, J Zhang, L. Vila, J. Reveille, G. Alarcon, and for the LUMINA study group
Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort
Lupus,
August 1, 2009;
18(9):
822 - 830.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Descloux, I. Durieu, P. Cochat, D. Vital-Durand, J. Ninet, N. Fabien, and R. Cimaz
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus
Rheumatology,
July 1, 2009;
48(7):
779 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Pons-Estel, L. A. Gonzalez, J. Zhang, P. I. Burgos, J. D. Reveille, L. M. Vila, and G. S. Alarcon
Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort
Rheumatology,
July 1, 2009;
48(7):
817 - 822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zonana-Nacach, P. Yanez, F.J. Jimenez-Balderas, and A. Camargo-Coronel
Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus
Lupus,
December 1, 2007;
16(12):
997 - 1000.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L M Vila, M J Molina, A M Mayor, R A Peredo, M L Santaella, and S Vila
Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus
Lupus,
December 1, 2006;
15(12):
892 - 898.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S J Walsh and A Gilchrist
Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation
Lupus,
October 1, 2006;
15(10):
662 - 670.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M Bandeira, S Buratti, M Bartoli, C Gasparini, L Breda, A Pistorio, S Grassi, M. Alpigiani, G Barbano, L. Janz-Junior, et al.
Relationship between Damage Accrual, Disease Flares and Cumulative Drug Therapies in Juvenile-Onset Systemic Lupus Erythematosus
Lupus,
August 1, 2006;
15(8):
515 - 520.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R Prasad, D Ibanez, D Gladman, and M Urowitz
Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus
Lupus,
May 1, 2006;
15(5):
285 - 291.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A M Bertoli, G S Alarcon, G McGwin, M Fernandez, H M Bastian, B J Fessler, L M Vila, J D Reveille, and LUMINA Study Group
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity
Lupus,
January 1, 2006;
15(1):
13 - 18.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, J Ugalde, and C Aguirre
Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus
Lupus,
December 1, 2004;
13(12):
900 - 905.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Medina, O Vera-Lastra, L Barile, M Salas, and L J Jara
Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients
Lupus,
January 1, 2004;
13(1):
11 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Soares, L Reis, J A. Papi, and C R. Cardoso
Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients
Lupus,
October 1, 2003;
12(10):
788 - 794.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S Sundaramurthy, T M Bush, C M Neuwelt, and M M Ward
Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus
Lupus,
June 1, 2003;
12(6):
443 - 448.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J Calvo-Alen, J D Reveille, V Rodriguez-Valverde, G McGwin Jr, B A Baethge, A W Friedman, and G S Alarcon
Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry
Lupus,
May 1, 2003;
12(5):
377 - 385.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C.-S. Yee, H. Hussein, J. Skan, S. Bowman, D. Situnayake, and C. Gordon
Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus
Rheumatology,
February 1, 2003;
42(2):
276 - 279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P V Voulgari, P Katsimbri, Y Alamanos, and A A Drosos
Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature
Lupus,
November 1, 2002;
11(11):
722 - 729.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y Molad, A Gorshtein, A J Wysenbeek, D Guedj, R Majadla, A Weinberger, and M Amit-Vazina
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{
Lupus,
June 1, 2002;
11(6):
356 - 361.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S J Walsh and L M Dechello
Geographical variation in mortality from systemic lupus erythematosus in the United States
Lupus,
September 1, 2001;
10(9):
637 - 646.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P Rahman, D D Gladman, M B Urowitz, D Hallett, and L S Tam
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus
Lupus,
February 1, 2001;
10(2):
93 - 96.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D D Gladman and M. B Urowitz
The SLICC/ACR damage index: progress report and experience in the field
Lupus,
October 1, 1999;
8(8):
632 - 637.
[Abstract]
[PDF]
|
|
|
|
|
